Transient receptor potential melastatin 3 dysfunction in post COVID-19 condition and myalgic encephalomyelitis/chronic fatigue syndrome patients

• Váldodahkkit: Etianne Martini Sasso (Dahkki), Katsuhiko Muraki (Dahkki), Natalie Eaton-Fitch (Dahkki), Peter Smith (Dahkki), Olivia Ly Lesslar (Dahkki), Gary Deed (Dahkki), Sonya Marshall-Gradisnik (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: BMC, 2022-08-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Abstract Background Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a severe multisystemic condition associated with post-infectious onset, impaired natural killer (NK) cell cytotoxicity and impaired ion channel function, namely Transient Receptor Potential Melastatin 3 (TRPM3). Long-...